Acne Vulgaris Medicament Management in Indonesia and the Efficacy of Various Therapeutic Regimens

Maria Clarissa Wiraputranto; Irma Bernadette S. Sitohang; Windy Keumala Budianti; Adhimukti T. Sampurna

doi:10.3889/oamjms.2023.11576

Authors

Maria Clarissa Wiraputranto Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia https://orcid.org/0000-0002-9123-3867
Irma Bernadette S. Sitohang Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia
Windy Keumala Budianti Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia https://orcid.org/0000-0002-9613-7698
Adhimukti T. Sampurna Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2023.11576

Keywords:

acne vulgaris, efficacy, guidelines, grading system, management

Abstract

BACKGROUND: Acne vulgaris (AV) is an inflammatory disease of the pilosebaceous unit with various pleomorphic lesions. In Indonesia, AV is the third most common case that makes patients come to seek treatment at the Hospital. The diagnosis can be established clinically and the AV grading system can be used to assess the severity. Until now, there are many AV grading systems and guidelines for AV. At Dr. Cipto Mangunkusumo Hospital uses Lehmann’s grading system.

AIM: The aims of this review were to summarize the current guidelines for AV therapy in Indonesia and assess the efficacy of various therapeutic regimens.

METHODS: We conducted a comprehensive literature search using the search engines PubMed, Scopus, Research Gate, and Google Scholar in the time frame 2015 until 2022 with a total of 431 articles, and 29 studies met the inclusion criteria. The studies reported a total of 8245 participants.

RESULTS AND DISCUSSION: AV management may differ according to the conditions of each country. There are two therapeutic modalities for AV medication management, topical and systemic. The choice of therapy must be adjusted to the patient’s needs, AV severity, and drug efficacy, taking into account the risk and benefit factors of the drug, as well as psychosocial factors.

CONCLUSION: Management of AV is still a challenge because the therapy in different countries is not the same. It is necessary to know the etiopathogenesis, understand patient’s condition and the severity of AV, also know the efficacy of AV therapy, and consider treatment recommendations based on existing guidelines so that the treatment results can be achieved optimally.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Goh C, Cheng C, Agak G, Zaenglein AL, Graber EM, Thiboutot DM, et al. Acne vulgaris. In: Kang S, Amagai M, Bruckner A, editors. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill; 2019. p. 1391-418.

Zaenglein AL. Acne vulgaris. N Engl J Med. 2018;379(14):1343-52. https://doi.org/10.1056/nejmcp1702493 PMid:30281982 DOI: https://doi.org/10.1056/NEJMcp1702493

Wasitaatmadja SM, Arimuko A, Norawati L, Bernadette I, Legiawati L. Acne Treatment Guidelines in Indonesia. [Pedoman Tata Laksana Akne di Indonesia]. 2nd ed. Jakarta: Centra Communications; 2016. p. 1-13.

Sutaria AH, Masood S, Schlessinger J. Acne Vulgaris. Treasure Island: StatPearls Publishing; 2022. Available from: https://www. ncbi.nlm.nih.gov/books/nbk459173/?report=printable [Last accessed on 2022 Jul 12].

Heng AH, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):5754. https://doi.org/10.1038/ s41598-020-62715-3 PMid:32238884 DOI: https://doi.org/10.1038/s41598-020-62715-3

Department of Dermatology and Venereology. Patient Visit Data of Cosmetic Dermatology Division, Polyclinic Dermatology and Venereology Department RSUPN Dr. Cipto Mangunkusumo in 2017-2019 [Data Kunjungan Pasien Poliklinik Divisi Kosmetik Departemen Dermatologi dan Venereologi RSUPN Dr. Cipto Mangunkusumo Tahun 2017-2019]; 2019. p. 1-10.

Wasitaatmadja SM. Acne. [Akne]. Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2018. p. 1-199.

Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch. Dermatol Res. 2019;311(5):337-49. https://doi.org/10.1007/s00403-019-01908-x PMid:30859308 DOI: https://doi.org/10.1007/s00403-019-01908-x

Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Dermatology: How to manage acne vulgaris. Drugs Context. 2020;10:1-18. https://doi.org/10.7573/dic.2021-8-6 PMid:34691199 DOI: https://doi.org/10.7573/dic.2021-8-6

Ogé LK, Broussard A, Marshall MD. Acne vulgaris: Diagnosis and treatment. Am Fam Physician. 2019;100(8):475-84. PMid:31613567

Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. Int J Womens Dermatol. 2018;4(2):56-71. https://doi.org/10.1016/j.ijwd.2017.10.006 PMid:29872679 DOI: https://doi.org/10.1016/j.ijwd.2017.10.006

Thiboutot DM, Dréno B, Abanmi A, Alexis AF, Araviiskaia E, Cabal MI, et al. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(2 Suppl 1):S1-23.e1. https://doi.org/10.1016/j.jaad.2017.09.078 PMid:29127053 DOI: https://doi.org/10.1016/j.jaad.2017.09.078

Indonesian Society of Dermatology and Venereology (PERDOSKI). Acne vulgaris. In: Siswati AS, Rosita C, Triwahyudi D, Budianti KB, Mawardi P, Dwiyana RF, et al., editors. Clinical Practice Guidelines for Indonesian Dermatologist and Venereologists. [Panduan Praktis Klinis Bagi Dokter Dermatologi dan Venereologi Indonesia]. Jakarta: PP PERDOSKI; 2021. p. 343-6.

Department Dermatology and Venereology. Clinical Practice Guidelines for Acne Vulgaris RSCM. [Panduan Praktis Klinis Akne Vulgaris RSCM]. Jakarta: RSCM; 2022. p. 5-26.

Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.e33. https://doi.org/10.1016/j.jaad.2015.12.037 PMid:26897386 DOI: https://doi.org/10.1016/j.jaad.2015.12.037

Nast A, Dréno B, Bettoli V, Mokos ZB, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne update 2016-short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261-8. https://doi.org/10.1111/jdv.13776 PMid:27514932 DOI: https://doi.org/10.1111/jdv.13776

Goh CL, Abad-Casintahan F, Aw DC, Baba R, Chan LC, Hung NT, et al. South-EastAsia study alliance guidelines on the management of acne vulgaris in South-East Asian patients. J Dermatol. 2015;42(10):945-53. https://doi.org/10.1111/1346-8138.12993 PMid:26211507 DOI: https://doi.org/10.1111/1346-8138.12993

Oon H, Wong SN, Chen WA, Cheong WK, Goh CL, Tan HH. Acne management guidelines by the dermatological society of Singapore. J Clin Aesthet Dermatol. 2019;12(7):34-50. PMid:31531161

Kolli SS, Pecone D, Pona A, Cline A, Feldman SR. Topical retinoids in acne vulgaris: A systematic review. Am J Clin Dermatol.

;20(3):345-65. https://doi.org/10.1007/s40257-019-00423-z PMid:30674002 DOI: https://doi.org/10.1007/s40257-019-00423-z

Otlewska A, Baran W, Batycka-Baran A. Adverse events related to topical drug treatments for acne vulgaris. Expert Opin Drug Saf. 2020;19(4):513-21. https://doi.org/10.1080/14740338.2020.1757646 PMid:32347138 DOI: https://doi.org/10.1080/14740338.2020.1757646

Leyden JJ, Stein-Gold L, Weiss J. Why topical retinoids are mainstay of therapy for acne. Dermatol Ther (Heidelb). 2017;7(3):293-304. https://doi.org/10.1007/s13555-017-0185-2 PMid:28585191 DOI: https://doi.org/10.1007/s13555-017-0185-2

Ju Q, Fan WX, Gu J, Hao F, He L, Li HJ, et al. Chinese guidelines for the management of acne vulgaris: 2019 update. Int J Dermatol Venereol. 2019;2(3):129-38. https://doi.org/10.1097/JD9.0000000000000043 DOI: https://doi.org/10.1097/JD9.0000000000000043

Marson JW, Baldwin HE. An overview of acne therapy, part 1: Topical therapy, oral antibiotics, laser and light therapy, and dietary interventions. Dermatol Clin. 2019;37(2):183-93. https://doi.org/10.1016/j.det.2018.12.001 PMid:30850041 DOI: https://doi.org/10.1016/j.det.2018.12.001

Yang Z, Zhang Y, Mosler EL, Hu J, Li H, Zhang Y, et al. Topical benzoyl peroxide for acne. Cochrane Database Syst Rev. 2020;3(3):CD011154. https://doi.org/10.1002/14651858.CD011154.pub2 PMid:32175593 DOI: https://doi.org/10.1002/14651858.CD011154.pub2

Osman-Ponchet H, Sevin K, Gaborit A, Wagner N, Poncet M. Fixed-combination gels of adapalene and benzoyl peroxide provide optimal percutaneous absorption compared to monad formulations of these compounds: Results from two in vitro studies. Dermatol Ther (Heidelb). 2017;7(1):123-31. https://doi.org/10.1007/s13555-016-0159-9 PMid:27900658 DOI: https://doi.org/10.1007/s13555-016-0159-9

Baldwin H. Oral antibiotic treatment options for acne vulgaris. J Clin Aesthet Dermatol. 2020;13(9):26-32. PMid:33133338

Bienenfeld A, Nagler AR, Orlow SJ. Oral antibacterial therapy for acne vulgaris: An evidence-based review. Am J Clin Dermatol. 2017;18(4):469-90. https://doi.org/10.1007/s40257-017-0267-z PMid:28255924 DOI: https://doi.org/10.1007/s40257-017-0267-z

Sitohang IB, Fathan H, Effendi E, Wahid M. The susceptibility of pathogens associated with acne vulgaris to antibiotics. Med J Indones. 2019;28(1):21-7. https://doi.org/10.13181/mji.v28i1.2735 DOI: https://doi.org/10.13181/mji.v28i1.2735

Kardeh S, Saki N, Jowkar F, Kardeh B, Moein SA, Khorraminejad- Shirazi MH. Efficacy of azithromycin in treatment of acne vulgaris: A mini review. World J Plast Surg. 2019;8(2):127-34. https://doi.org/10.29252/wjps.8.2.127 PMid:31309049 DOI: https://doi.org/10.29252/wjps.8.2.127

Kim JE, Park AY, Lee SY, Park YL, Whang KU, Kim HJ. Comparison of the efficacy of azithromycin versus doxycycline in acne vulgaris: A meta-analysis of randomized controlled trials. Ann Dermatol. 2018;30(4):417-26. https://doi.org/10.5021/ad.2018.30.4.417 PMid:30065581 DOI: https://doi.org/10.5021/ad.2018.30.4.417

Mohiuddin AK. A comprehensive review of acne vulgaris. J Clin Pharm. 2019;1:17-45. https://doi.org/10.15226/2378-1726/6/2/00186 DOI: https://doi.org/10.15226/2378-1726/6/2/00186

Sitohang IB. Isotretinoin for treating acne vulgaris. Int J Appl Pharm. 2021;13(2):20-5. https://doi.org/10.22159/ijap.2021v13i2.40045 DOI: https://doi.org/10.22159/ijap.2021v13i2.40045

Vallerand IA, Lewinson RT, Farris MS, Sibley CD, Ramien ML, Bulloch AG, et al. Efficacy and adverse events of oral isotretinoin for acne: A systematic review. Br J Dermatol. 2018;178(1):76-85. https://doi.org/10.1111/bjd.15668 PMid:28542914 DOI: https://doi.org/10.1111/bjd.15668

Li C, Chen J, Wang W, Ai M, Zhang Q, Kuang L. Use of isotretinoin

and risk of depression in patients with acne: A systematic review and meta-analysis. BMJ Open. 2019;9(1):e021549. https://doi.org/10.1136/bmjopen-2018-021549 PMid:30670500 DOI: https://doi.org/10.1136/bmjopen-2018-021549

Conforti C, Giuffrida R, Fadda S, Fai A, Romita P, Zalaudek I, et al. Topical dermocosmetics and acne vulgaris. Dermatol Ther. 2021;34(4):e14436. https://doi.org/10.1111/dth.14436 PMid:33084158 DOI: https://doi.org/10.1111/dth.14436

Araviiskaia E, Estebaranz JL, Pincelli C. Dermocosmetics: Beneficial adjuncts in the treatment of acne vulgaris. J Dermatolog Treat. 2021;32(1):3-10. https://doi.org/10.1080/09546634.2019.1628173 PMid:31211609 DOI: https://doi.org/10.1080/09546634.2019.1628173

Goh CL, Wu Y, Welsh B, Abad-Casintahan MF, Tseng CJ, Sharad J, et al. Expert consensus on holistic skin care routine: Focus on acne, rosacea, atopic dermatitis, and sensitive skin syndrome. J Cosmet Dermatol. 2022;22(1):45-54. https://doi.org/10.1111/jocd.15519 PMid:36409588 DOI: https://doi.org/10.1111/jocd.15519

Sitohang IB, Yahya YF, Simanungkalit R, Winarni DR, Madjid A. Efficacy and tolerability of topical nicotinamide plus antibacterial adhesive agents and zinc-pyrrolidone carboxylic acid versus placebo as an adjuvant treatment for moderate acne vulgaris in Indonesia: A multicenter, double-blind, randomized, controlled trial. J Clin Aesthet Dermatol. 2020;13(7):27-31. PMid:32983333

Sitohang IB, Soebaryo RW, Kanoko M. Acne lesion extraction versus oral doxycycline for moderate acne vulgaris: A randomized clinical trial. J Clin Aesthet Dermatol. 2021;14(6):E61-5. PMid:34804358

Sutarjo AS, Sitohang IB, Wahid MH, Widaty S. Comparison of Malassezia spp. Proportions in inflammatory and non- inflammatory facial acne vulgaris lesions. Int J Appl Pharm. 2020;12(3):7-11. https://doi.org/10.22159/ijap.2020.v12s3.39454 DOI: https://doi.org/10.22159/ijap.2020.v12s3.39454

Saptarini D, Witjaksono F, Sitohang IB. Correlation study of acne vulgaris and serum Vitamin D levels in adolescents. Int J Appl Pharm. 2020;12(3):19-21. https://doi.org/10.22159/ijap.2020.v12s3.39462 DOI: https://doi.org/10.22159/ijap.2020.v12s3.39462